Rating History for Enliven Therapeutics (ELVN) by William Blair
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | Andy Hsieh | New Coverage | Outperform (N/A) |
N/A (N/A) |
59.53 (57.86) |
-2.81% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | Andy Hsieh | New Coverage | Outperform (N/A) |
N/A (N/A) |
59.53 (57.86) |
-2.81% | Details |